
The party drug and anesthetic ketamine is starting to show promise in trials as a treatment for depression. But new research also suggests that hundreds of U.S. clinics may be misleading consumers, hawking off-label and unapproved ketamine to treat a variety of mental health and pain conditions. “These are expensive treatments for which patients generally… read on > read on >